Dec 7, 2022
Featuring perspectives from Prof Karim Fizazi and Prof Stéphane Oudard, including the following topics:
Nov 9, 2022
Featuring perspectives from Dr Matthew Smith, including the following topics:
Jul 14, 2022
PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We’re Headed — Faculty Presentation 2: Available Data with, Ongoing Investigation of and Potential Future Role of PARP Inhibitor-Based Combination Strategies — Dr Fred Saad
Jul 14, 2022
PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We’re Headed — Faculty Presentation 1: Optimal Integration of PARP Inhibitor Monotherapy into the Management of Metastatic Castration-Resistant Prostate Cancer — Prof Johann de Bono
Jul 14, 2022